Annual report
9265.TEDINET S100P29L
Period2021-06-01 → 2022-05-31
Filed2022-08-26
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 148
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥55.1bn | 2021-06-01 → 2022-05-31 | Cons. | Net sales |
| Revenue | ¥70.1bn | 2020-06-01 → 2021-05-31 | Cons. | Net sales |
| Revenue | ¥64.7bn | 2019-06-01 → 2020-05-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥61.5bn | 2018-06-01 → 2019-05-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥58.7bn | 2017-06-01 → 2018-05-31d | Cons. | Net sales (5-year summary) |
| Operating income | ¥931m | 2021-06-01 → 2022-05-31 | Cons. | Operating income |
| Operating income | ¥969m | 2020-06-01 → 2021-05-31 | Cons. | Operating income |
| Ordinary income | ¥1.0bn | 2021-06-01 → 2022-05-31 | Cons. | Ordinary income |
| Ordinary income | ¥1.0bn | 2020-06-01 → 2021-05-31 | Cons. | Ordinary income |
| Ordinary income | ¥643m | 2019-06-01 → 2020-05-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥617m | 2018-06-01 → 2019-05-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥450m | 2017-06-01 → 2018-05-31d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥1.0bn | 2021-06-01 → 2022-05-31 | Cons. | Income before income taxes |
| Profit before tax | ¥1.1bn | 2020-06-01 → 2021-05-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥696m | 2021-06-01 → 2022-05-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥678m | 2020-06-01 → 2021-05-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥460m | 2019-06-01 → 2020-05-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥144m | 2018-06-01 → 2019-05-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥221m | 2017-06-01 → 2018-05-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥695m | 2021-06-01 → 2022-05-31 | Cons. | Profit loss |
| Net income | ¥678m | 2020-06-01 → 2021-05-31 | Cons. | Profit loss |
| Total assets | ¥24.1bn | at 2022-05-31 | Cons. | Assets |
| Total assets | ¥24.3bn | at 2021-05-31 | Cons. | Assets |
| Total assets | ¥21.4bn | at 2020-05-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥20.3bn | at 2019-05-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥20.8bn | at 2018-05-31d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥16.1bn | at 2022-05-31 | Cons. | Liabilities |
| Total liabilities | ¥16.7bn | at 2021-05-31 | Cons. | Liabilities |
| Net assets / equity | ¥8.0bn | at 2022-05-31 | Cons. | Net assets |
| Net assets / equity | ¥7.6bn | at 2021-05-31 | Cons. | Net assets |
| Net assets / equity | ¥6.9bn | at 2020-05-31d | Cons. | Net assets |
| Net assets / equity | ¥6.4bn | at 2019-05-31d | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥6.3bn | at 2018-05-31d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥4.0bn | at 2022-05-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥3.7bn | at 2021-05-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥4.0bn | at 2022-05-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥3.7bn | at 2021-05-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥3.0bn | at 2020-05-31d | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.3bn | at 2019-05-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥2.8bn | at 2018-05-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥581m | 2021-06-01 → 2022-05-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥912m | 2020-06-01 → 2021-05-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥818m | 2019-06-01 → 2020-05-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥101m | 2018-06-01 → 2019-05-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥1.5bn | 2017-06-01 → 2018-05-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥28m | 2021-06-01 → 2022-05-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥134m | 2020-06-01 → 2021-05-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥34m | 2019-06-01 → 2020-05-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | ¥50m | 2018-06-01 → 2019-05-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥378m | 2017-06-01 → 2018-05-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥230m | 2021-06-01 → 2022-05-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥138m | 2020-06-01 → 2021-05-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥107m | 2019-06-01 → 2020-05-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥366m | 2018-06-01 → 2019-05-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥353m | 2017-06-01 → 2018-05-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥272.67 | 2021-06-01 → 2022-05-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥265.77 | 2020-06-01 → 2021-05-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥180.07 | 2019-06-01 → 2020-05-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥56.57 | 2018-06-01 → 2019-05-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥87.04 | 2017-06-01 → 2018-05-31d | Cons. | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥3,126.18 | at 2022-05-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥2,969.03 | at 2021-05-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥2,717.81 | at 2020-05-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥2,496.1 | at 2019-05-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥2,457.18 | at 2018-05-31d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 33.1% | at 2022-05-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 31.2% | at 2021-05-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 32.4% | at 2020-05-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 31.4% | at 2019-05-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 30.1% | at 2018-05-31d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 8.9% | 2021-06-01 → 2022-05-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 9.3% | 2020-06-01 → 2021-05-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 6.9% | 2019-06-01 → 2020-05-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 2.3% | 2018-06-01 → 2019-05-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 3.6% | 2017-06-01 → 2018-05-31d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 574 | at 2022-05-31 | Cons. | Number of employees |
| Employees | 553 | at 2021-05-31 | Cons. | Number of employees |
| Employees | 551 | at 2020-05-31d | Cons. | Number of employees |
| Employees | 552 | at 2019-05-31d | Cons. | Number of employees |
| Employees | 556 | at 2018-05-31d | Cons. | Number of employees |
| Revenue | ¥793m | 2021-06-01 → 2022-05-31 | Standalone | Operating revenue1 |
| Revenue | ¥854m | 2020-06-01 → 2021-05-31 | Standalone | Operating revenue1 |
| Revenue | ¥509m | 2019-06-01 → 2020-05-31d | Standalone | Operating revenue1 (5-year summary) |
| Revenue | ¥448m | 2018-06-01 → 2019-05-31d | Standalone | Operating revenue1 (5-year summary) |
| Revenue | ¥280m | 2017-06-01 → 2018-05-31d | Standalone | Operating revenue1 (5-year summary) |
| Operating income | ¥228m | 2021-06-01 → 2022-05-31 | Standalone | Operating income |
| Operating income | ¥346m | 2020-06-01 → 2021-05-31 | Standalone | Operating income |
| Ordinary income | ¥228m | 2021-06-01 → 2022-05-31 | Standalone | Ordinary income |
| Ordinary income | ¥347m | 2020-06-01 → 2021-05-31 | Standalone | Ordinary income |
| Ordinary income | ¥137m | 2019-06-01 → 2020-05-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥128m | 2018-06-01 → 2019-05-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥108m | 2017-06-01 → 2018-05-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥228m | 2021-06-01 → 2022-05-31 | Standalone | Income before income taxes |
| Profit before tax | ¥347m | 2020-06-01 → 2021-05-31 | Standalone | Income before income taxes |
| Net income | ¥228m | 2021-06-01 → 2022-05-31 | Standalone | Profit loss |
| Net income | ¥348m | 2020-06-01 → 2021-05-31 | Standalone | Profit loss |
| Net income | ¥101m | 2019-06-01 → 2020-05-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥125m | 2018-06-01 → 2019-05-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥101m | 2017-06-01 → 2018-05-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥6.5bn | at 2022-05-31 | Standalone | Assets |
| Total assets | ¥6.4bn | at 2021-05-31 | Standalone | Assets |
| Total assets | ¥6.0bn | at 2020-05-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥5.9bn | at 2019-05-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥5.9bn | at 2018-05-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥499m | at 2022-05-31 | Standalone | Liabilities |
| Total liabilities | ¥331m | at 2021-05-31 | Standalone | Liabilities |
| Net assets / equity | ¥6.0bn | at 2022-05-31 | Standalone | Net assets |
| Net assets / equity | ¥6.0bn | at 2021-05-31 | Standalone | Net assets |
| Net assets / equity | ¥5.8bn | at 2020-05-31d | Standalone | Net assets |
| Net assets / equity | ¥5.8bn | at 2019-05-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥5.8bn | at 2018-05-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥229m | at 2022-05-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥401m | at 2021-05-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥89.32 | 2021-06-01 → 2022-05-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥136.46 | 2020-06-01 → 2021-05-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥39.38 | 2019-06-01 → 2020-05-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥48.96 | 2018-06-01 → 2019-05-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥39.5 | 2017-06-01 → 2018-05-31d | Standalone | Basic earnings loss per share (5-year summary) |
| Dividend per share | ¥82 | 2021-06-01 → 2022-05-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥90 | 2020-06-01 → 2021-05-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥54 | 2019-06-01 → 2020-05-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥42 | 2018-06-01 → 2019-05-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥26 | 2017-06-01 → 2018-05-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥2,360.07 | at 2022-05-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥2,360.75 | at 2021-05-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥2,278.24 | at 2020-05-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥2,280.98 | at 2019-05-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥2,258.01 | at 2018-05-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 92.4% | at 2022-05-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 94.8% | at 2021-05-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 96.9% | at 2020-05-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 99.2% | at 2019-05-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 98.5% | at 2018-05-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 3.8% | 2021-06-01 → 2022-05-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 5.9% | 2020-06-01 → 2021-05-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 1.7% | 2019-06-01 → 2020-05-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 2.2% | 2018-06-01 → 2019-05-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 1.7% | 2017-06-01 → 2018-05-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 2,553,000 | at 2022-05-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 2,553,000 | at 2021-05-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 2,553,000 | at 2020-05-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 2,553,000 | at 2019-05-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 2,553,000 | at 2018-05-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 27 | at 2022-05-31 | Standalone | Number of employees |
| Employees | 24 | at 2021-05-31 | Standalone | Number of employees |
| Employees | 20 | at 2020-05-31d | Standalone | Number of employees |
| Employees | 19 | at 2019-05-31d | Standalone | Number of employees |
| Employees | 20 | at 2018-05-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 48
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | depreciation | 2021-06-01 → 2022-05-31 | ¥36m |
| Reconciling Itemsreconciling | revenue | 2021-06-01 → 2022-05-31 | −¥6m |
| Reconciling Itemsreconciling | revenue intersegment | 2021-06-01 → 2022-05-31 | −¥6m |
| Reconciling Itemsreconciling | segment profit | 2021-06-01 → 2022-05-31 | −¥1.0bn |
| Medical Equipment Manufacturing And Salesreportable segment | depreciation | 2021-06-01 → 2022-05-31 | ¥7m |
| Medical Equipment Manufacturing And Salesreportable segment | employees | at 2022-05-31 | 5 pure |
| Medical Equipment Manufacturing And Salesreportable segment | revenue | 2021-06-01 → 2022-05-31 | ¥288m |
| Medical Equipment Manufacturing And Salesreportable segment | revenue external | 2021-06-01 → 2022-05-31 | ¥287m |
| Medical Equipment Manufacturing And Salesreportable segment | revenue intersegment | 2021-06-01 → 2022-05-31 | ¥385,000 |
| Medical Equipment Manufacturing And Salesreportable segment | segment profit | 2021-06-01 → 2022-05-31 | ¥20m |
| Medical Equipment Salesreportable segment | depreciation | 2021-06-01 → 2022-05-31 | ¥142m |
| Medical Equipment Salesreportable segment | employees | at 2022-05-31 | 527 pure |
| Medical Equipment Salesreportable segment | revenue | 2021-06-01 → 2022-05-31 | ¥54.8bn |
| Medical Equipment Salesreportable segment | revenue external | 2021-06-01 → 2022-05-31 | ¥54.8bn |
| Medical Equipment Salesreportable segment | revenue intersegment | 2021-06-01 → 2022-05-31 | ¥6m |
| Medical Equipment Salesreportable segment | segment profit | 2021-06-01 → 2022-05-31 | ¥2.0bn |
| Medical Mallreportable segment | depreciation | 2021-06-01 → 2022-05-31 | ¥15m |
| Medical Mallreportable segment | revenue | 2021-06-01 → 2022-05-31 | ¥69m |
| Medical Mallreportable segment | revenue external | 2021-06-01 → 2022-05-31 | ¥69m |
| Medical Mallreportable segment | segment profit | 2021-06-01 → 2022-05-31 | −¥47m |
| —segment total | depreciation | 2021-06-01 → 2022-05-31 | ¥164m |
| —segment total | revenue | 2021-06-01 → 2022-05-31 | ¥55.2bn |
| —segment total | revenue external | 2021-06-01 → 2022-05-31 | ¥55.1bn |
| —segment total | revenue intersegment | 2021-06-01 → 2022-05-31 | ¥6m |
| —segment total | segment profit | 2021-06-01 → 2022-05-31 | ¥1.9bn |
| Reconciling Itemsreconciling | depreciation | 2020-06-01 → 2021-05-31 | ¥36m |
| Reconciling Itemsreconciling | revenue | 2020-06-01 → 2021-05-31 | −¥18m |
| Reconciling Itemsreconciling | revenue intersegment | 2020-06-01 → 2021-05-31 | −¥18m |
| Reconciling Itemsreconciling | segment profit | 2020-06-01 → 2021-05-31 | −¥854m |
| Medical Equipment Manufacturing And Salesreportable segment | depreciation | 2020-06-01 → 2021-05-31 | ¥8m |
| Medical Equipment Manufacturing And Salesreportable segment | revenue | 2020-06-01 → 2021-05-31 | ¥360m |
| Medical Equipment Manufacturing And Salesreportable segment | revenue external | 2020-06-01 → 2021-05-31 | ¥359m |
| Medical Equipment Manufacturing And Salesreportable segment | revenue intersegment | 2020-06-01 → 2021-05-31 | ¥348,000 |
| Medical Equipment Manufacturing And Salesreportable segment | segment profit | 2020-06-01 → 2021-05-31 | ¥72m |
| Medical Equipment Salesreportable segment | depreciation | 2020-06-01 → 2021-05-31 | ¥126m |
| Medical Equipment Salesreportable segment | revenue | 2020-06-01 → 2021-05-31 | ¥69.7bn |
| Medical Equipment Salesreportable segment | revenue external | 2020-06-01 → 2021-05-31 | ¥69.7bn |
| Medical Equipment Salesreportable segment | revenue intersegment | 2020-06-01 → 2021-05-31 | ¥17m |
| Medical Equipment Salesreportable segment | segment profit | 2020-06-01 → 2021-05-31 | ¥1.7bn |
| Medical Mallreportable segment | depreciation | 2020-06-01 → 2021-05-31 | ¥14m |
| Medical Mallreportable segment | revenue | 2020-06-01 → 2021-05-31 | ¥67m |
| Medical Mallreportable segment | revenue external | 2020-06-01 → 2021-05-31 | ¥67m |
| Medical Mallreportable segment | segment profit | 2020-06-01 → 2021-05-31 | ¥1m |
| —segment total | depreciation | 2020-06-01 → 2021-05-31 | ¥148m |
| —segment total | revenue | 2020-06-01 → 2021-05-31 | ¥70.1bn |
| —segment total | revenue external | 2020-06-01 → 2021-05-31 | ¥70.1bn |
| —segment total | revenue intersegment | 2020-06-01 → 2021-05-31 | ¥18m |
| —segment total | segment profit | 2020-06-01 → 2021-05-31 | ¥1.8bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,328
| Item | Context | Value | Unit |
|---|---|---|---|
| Interest and dividends income ope cf | CurrentYearDuration | -10155000 | JPY |
| Interest expenses ope cf | Prior1YearDuration | 4184000 | JPY |
| Interest expenses ope cf | CurrentYearDuration | 3859000 | JPY |
| Receipts from contingent consideration ope cf | Prior1YearDuration | -24965000 | JPY |
| Receipts from contingent consideration ope cf | CurrentYearDuration | -17297000 | JPY |
| Loss gain on step acquisitions ope cf | Prior1YearDuration | － | JPY |
| Loss gain on step acquisitions ope cf | CurrentYearDuration | -4238000 | JPY |
| Equity in earnings losses of affiliates ope cf | Prior1YearDuration | -5178000 | JPY |
| Equity in earnings losses of affiliates ope cf | CurrentYearDuration | -10377000 | JPY |
| Decrease increase in notes and accounts receivable trade ope cf | Prior1YearDuration | -2005088000 | JPY |
| Decrease increase in notes and accounts receivable trade ope cf | CurrentYearDuration | 247112000 | JPY |
| Decrease increase in inventories ope cf | Prior1YearDuration | -200732000 | JPY |
| Decrease increase in inventories ope cf | CurrentYearDuration | 241125000 | JPY |
| Increase decrease in notes and accounts payable trade ope cf | Prior1YearDuration | 2081682000 | JPY |
| Increase decrease in notes and accounts payable trade ope cf | CurrentYearDuration | -604909000 | JPY |
| Other net ope cf | Prior1YearDuration | 102050000 | JPY |
| Other net ope cf | CurrentYearDuration | -13235000 | JPY |
| Subtotal ope cf | Prior1YearDuration | 1135570000 | JPY |
| Subtotal ope cf | CurrentYearDuration | 1005230000 | JPY |
| Interest and dividends income received ope cf inv cf | Prior1YearDuration | 7924000 | JPY |
| Interest and dividends income received ope cf inv cf | CurrentYearDuration | 59572000 | JPY |
| Interest expenses paid ope cf fin cf | Prior1YearDuration | -4163000 | JPY |
| Interest expenses paid ope cf fin cf | CurrentYearDuration | -3828000 | JPY |
| Income taxes paid ope cf | Prior1YearDuration | -258210000 | JPY |
| Income taxes paid ope cf | CurrentYearDuration | -488125000 | JPY |
| Income taxes refund ope cf | Prior1YearDuration | 30406000 | JPY |
| Income taxes refund ope cf | CurrentYearDuration | 8418000 | JPY |
| Net cash provided by used in operating activities | Prior1YearDuration | 911528000 | JPY |
| Net cash provided by used in operating activities | CurrentYearDuration | 581267000 | JPY |
| Purchase of short term investment securities inv cf | Prior1YearDuration | － | JPY |
| Purchase of short term investment securities inv cf | CurrentYearDuration | -300000000 | JPY |
| Proceeds from sales of short term investment securities inv cf | Prior1YearDuration | － | JPY |
| Proceeds from sales of short term investment securities inv cf | CurrentYearDuration | 300000000 | JPY |
| Purchase of property plant and equipment inv cf | Prior1YearDuration | -145333000 | JPY |
| Purchase of property plant and equipment inv cf | CurrentYearDuration | -107330000 | JPY |
| Purchase of intangible assets inv cf | Prior1YearDuration | -900000 | JPY |
| Purchase of intangible assets inv cf | CurrentYearDuration | -11230000 | JPY |
| Purchase of investment securities inv cf | Prior1YearDuration | -3724000 | JPY |
| Purchase of investment securities inv cf | CurrentYearDuration | -33909000 | JPY |
| Proceeds from contingent consideration inv cf | Prior1YearDuration | 24965000 | JPY |
| Proceeds from contingent consideration inv cf | CurrentYearDuration | 17297000 | JPY |
| Proceeds from purchase of investments in subsidiaries resulting in change in scope of consolidation inv cf | Prior1YearDuration | － | JPY |
| Proceeds from purchase of investments in subsidiaries resulting in change in scope of consolidation inv cf | CurrentYearDuration | 100172000 | JPY |
| Other net inv cf | Prior1YearDuration | -9150000 | JPY |
| Other net inv cf | CurrentYearDuration | 7340000 | JPY |
| Net cash provided by used in investment activities | Prior1YearDuration | -134143000 | JPY |
| Net cash provided by used in investment activities | CurrentYearDuration | -27660000 | JPY |
| Cash dividends paid fin cf | Prior1YearDuration | -137813000 | JPY |
| Cash dividends paid fin cf | CurrentYearDuration | -229998000 | JPY |
| Net cash provided by used in financing activities | Prior1YearDuration | -137813000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |